CIC bioGUNE, Basque Research Technology Alliance, BRTA, Bizkaia Technology park, Building 800, 48160, Derio, Spain.
Centro de Investigaciones Biológicas Margarita Salas, CSIC, Ramiro de Maeztu 9, 28040, Madrid, Spain.
Chembiochem. 2020 Nov 2;21(21):2999-3025. doi: 10.1002/cbic.202000238. Epub 2020 Jul 2.
Carbohydrates play a pivotal role in intercellular communication processes. In particular, glycan antigens are key for sustaining homeostasis, helping leukocytes to distinguish damaged tissues and invading pathogens from healthy tissues. From a structural perspective, this cross-talk is fairly complex, and multiple membrane proteins guide these recognition processes, including lectins and Toll-like receptors. Since the beginning of this century, lectins have become potential targets for therapeutics for controlling and/or avoiding the progression of pathologies derived from an incorrect immune outcome, including infectious processes, cancer, or autoimmune diseases. Therefore, a detailed knowledge of these receptors is mandatory for the development of specific treatments. In this review, we summarize the current knowledge about four key C-type lectins whose importance has been steadily growing in recent years, focusing in particular on how glycan recognition takes place at the molecular level, but also looking at recent progresses in the quest for therapeutics.
碳水化合物在细胞间通讯过程中起着关键作用。特别是,糖抗原是维持内稳态的关键,帮助白细胞将受损组织和入侵病原体与健康组织区分开来。从结构的角度来看,这种交流非常复杂,多种膜蛋白指导这些识别过程,包括凝集素和 Toll 样受体。自本世纪初以来,凝集素已成为控制和/或避免源自不正确免疫结果的病理进展的治疗潜在靶点,包括感染过程、癌症或自身免疫性疾病。因此,详细了解这些受体对于开发特定的治疗方法是必要的。在这篇综述中,我们总结了近年来一直稳步增长的四种关键 C 型凝集素的最新知识,特别关注糖识别如何在分子水平上发生,同时也关注治疗方法的最新进展。